Chemoinformaics analysis of 1-o-galloyl-2-o-cinnamoyl-beta-d-glucose
Molecular Weight | 204.357 | nRot | 1 |
Heavy Atom Molecular Weight | 180.165 | nRig | 12 |
Exact Molecular Weight | 204.188 | nRing | 2 |
Solubility: LogS | -5.326 | nHRing | 0 |
Solubility: LogP | 5.039 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 41.053 |
nHD | 0 | BPOL | 24.077 |
QED | 0.542 |
Synth | 4.492 |
Natural Product Likeliness | 3.055 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.055 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.417 |
MDCK | 0.0000146 |
BBB | 0.361 |
PPB | 0.955217 |
VDSS | 3.111 |
FU | 0.033073 |
CYP1A2-inh | 0.456 |
CYP1A2-sub | 0.507 |
CYP2c19-inh | 0.356 |
CYP2c19-sub | 0.914 |
CYP2c9-inh | 0.353 |
CYP2c9-sub | 0.716 |
CYP2d6-inh | 0.024 |
CYP2d6-sub | 0.472 |
CYP3a4-inh | 0.143 |
CYP3a4-sub | 0.331 |
CL | 12.902 |
T12 | 0.058 |
hERG | 0.025 |
Ames | 0.013 |
ROA | 0.047 |
SkinSen | 0.161 |
Carcinogencity | 0.688 |
EI | 0.444 |
Respiratory | 0.136 |
NR-Aromatase | 0.017 |
Antiviral | Yes |
Prediction | 0.891931 |